1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics 2022 - Europe (p3)

Healthcare Analysis & Statistics 2022 - Europe (p3)

61-90 of about 200 reports

ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diffuse large B-cell lymphoma (DLBCL) in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

Blinatumomab- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“BLINATUMOMAB - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B-cell lymphoma (DLBCL) in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Monoclonal Antibody
  • Industry analysis
  • Health Expenditure

DB-102- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“DB-102- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed ...

  • Europe
  • World
  • Lymphoma
  • Research And Development
  • Industry analysis
  • Health Expenditure

RG 7774 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“RG 7774 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diabetic Retinopathy in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Type 2 Diabetes
  • Research And Development
  • Industry analysis
  • Health Expenditure

Loncastuximab tesirine- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“LONCASTUXIMAB TESIRINE- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Therapy
  • Industry analysis
  • Health Expenditure

Treakisym- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“TREAKISYM - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

Ublituximab + Umbralisib- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“UBLITUXIMAB + UMBRALISIB - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse Large B-Cell Lymphoma in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Therapy
  • Industry analysis
  • Health Expenditure

ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Gaucher disease in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Research And Development
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Zydelig - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Zydelig - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Zydelig ...

  • Europe
  • Japan
  • Immunotherapy
  • Lymphoma
  • Industry analysis
  • Health Expenditure

PR001 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“PR001 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Gaucher disease in 7 Major Markets. A detailed picture of the PR001 ...

  • Europe
  • Japan
  • Research And Development
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure

Leustatin - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Leustatin - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ...

  • Europe
  • Japan
  • Clinical Trial
  • Leukemia
  • Industry analysis
  • Health Expenditure

Lumoxiti- Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Lumoxiti - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ...

  • Europe
  • Japan
  • Clinical Trial
  • Leukemia
  • Industry analysis
  • Health Expenditure

BIIB059 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“BIIB059 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cutaneous Lupus Erythematosus in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Dermatological Condition
  • Research And Development
  • Industry analysis
  • Health Expenditure

Delgocitinib - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“Delgocitinib - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Chronic Hand Eczema in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Dermatological Condition
  • Research And Development
  • Industry analysis
  • Health Expenditure

MB-102 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“MB-102 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Blastic Plasmacytoid Dendritic Cell Neoplasm in 7 Major Markets. ...

  • Europe
  • Japan
  • Cancer
  • Cell Therapy
  • Industry analysis
  • Health Expenditure

ASN002 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ASN002 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Chronic Hand Eczema in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Therapy
  • Research And Development
  • Industry analysis
  • Health Expenditure

Secukinumab - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“Secukinumab - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cutaneous Lupus Erythematosus in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Dermatological Condition
  • Industry analysis
  • Health Expenditure

VIB7734 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“VIB7734 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cutaneous Lupus Erythematosus in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Dermatological Condition
  • Research And Development
  • Industry analysis
  • Health Expenditure

XmAb14045 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“XmAb14045 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Blastic Plasmacytoid Dendritic Cell Neoplasm in 7 Major Markets. ...

  • Europe
  • Japan
  • Cell Therapy
  • Immunotherapy
  • Industry analysis
  • Health Expenditure

UniCAR02-T-CD123 - Emerging Drug Insight and Market forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“UniCAR02-T-CD123 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Blastic Plasmacytoid Dendritic Cell Neoplasm in 7 Majo ...

  • Europe
  • Japan
  • Cell Therapy
  • Research And Development
  • Industry analysis
  • Health Expenditure

IMGN632 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“IMGN632 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Blastic Plasmacytoid Dendritic Cell Neoplasm in 7 Major Markets. ...

  • Europe
  • Japan
  • Cell Therapy
  • Research And Development
  • Industry analysis
  • Health Expenditure

DEXMECAMYLAMINE- Emerging Insight and Market Forecast – 2030

  • $ 3250
  • February 2021
  • 30 pages

“DEXMECAMYLAMINE- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Palmar hyperhidrosis in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Dermatological Condition
  • Research And Development
  • Industry analysis
  • Health Expenditure

ELAFIBRANOR - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ELAFIBRANOR - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Primary Biliary Cirrhosis in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Autoimmune Disease
  • Research And Development
  • Industry analysis
  • Health Expenditure

SELADELPAR - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“SELADELPAR - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Primary Biliary Cirrhosis in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Autoimmune Disease
  • Research And Development
  • Industry analysis
  • Health Expenditure

Enhertu - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Enhertu - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Enhertu ...

  • Europe
  • Japan
  • Clinical Trial
  • Breast Cancer
  • Industry analysis
  • Health Expenditure

Kadcyla - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Kadcyla - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Kadcyla ...

  • Europe
  • Japan
  • Clinical Trial
  • Breast Cancer
  • Industry analysis
  • Health Expenditure
  • Drug Approval

Nerlynx - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Nerlynx - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Nerlynx ...

  • Europe
  • Japan
  • Clinical Trial
  • Breast Cancer
  • Industry analysis
  • Health Expenditure

BETALUTIN - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“BETALUTIN - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Follicular lymphoma in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

PEMBROLIZUMAB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“PEMBROLIZUMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Follicular lymphoma in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Lymphoma
  • Research And Development
  • Industry analysis
  • Health Expenditure

IXAZOMIB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“IXAZOMIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Follicular lymphoma in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Lymphoma
  • Research And Development
  • Industry analysis
  • Health Expenditure

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on